Cannabis Congress For Health Professionals In Mexico Illustrates Country’s Potential To Lead Marijuana Research – Benzinga

If North American cannabis legalization policy were an ice cream sandwich, Mexico would be the second cookie smashing the United States into Canada. Once again, the United States is set to sit and observe another neighboring country become “woke” about cannabis and legalize adult use of marijuana. Mexican Senate committees put forth draft legislation on October 17, 2019 to lift the country’s ban on the recreational marijuana use and possession. The country already legalized medical marijuana in 2017, and Mexico’s highest court recently determined that outlawing recreational cannabis was against the country’s constitution.

With a population of 127.6 million people, Mexico brings with it a total addressable market nearly three-and-a-half times the size of Canada’s, along with a more suitable climate to prolifically grow the plant. Mexico offers advantages in cannabis manufacturing and distribution with lower labor rates and geographical position as a hub Latin American markets

All these attributes make Mexico appealing for cannabis research and science, as well. Mexican scientists and researchers from other industries can be lured-in with higher pay and the sexiness of the industry. Mexico’s National Polytechnic Institute educates 100,000 undergraduate students a year, and that’s where I’d start looking for interns.

First, however, Mexican researchers need to get up to speed acquiring formal knowledge about the verifiable attributes of cannabis. Cannabis education needs to spread more broadly and expertly across the medical community. To that charter, CannabiSalud, the Cannabis Congress for Health Professionals in Mexico, hosted its 3rd annual conference October 31, 2019 through November 2, 2019 in Mexico City. Presented by SunMed, the two-day conference was established to help demystify and destigmatize the use of cannabis as a therapeutic treatment in the country.

International consultant and speaker, Lorena Beltrán-Franco, launched CannabiSalud to address the lack of cannabis education for health professionals in Mexico. “In the classrooms the subject is not touched, there are no guides that establish protocols on how to use the [different] medicines and how to dose them,” Beltrán-Franco said.

The research and case-study rich conference curriculum is geared towards medical professionals to include doctors, nurses, therapists, and pharmacists. CannabiSalud aims to become Latin America’s leading platform for destigmatizing cannabis use, and doing so via science. For American researchers, conducting cannabis science research in Mexico is often easier than trying to do so in the United States.

With a federally legal framework, Mexico will enable much-needed clinical cannabis research including full-scale clinical trials that U.S. laws have prohibited. “This is what the cannabis industry so desperately needs,” Wes Burk, the president at Emerald Scientific, told me in an interview. “The potential of this plant is very exciting, but we need the structure of good science and research to truly unlock all that potential.” 

Emerald Scientific joined the CannabiSalud this year as a gold sponsor. The company is known for its product quality assurance test, the “Emerald Test,” one of the largest cannabis tests of its type in the world. Offered twice a year, the test brings the cannabis industry a well-established standard for testing developed in the environmental, food, pharmaceutical, water, and petrochemical testing sectors.\

Burk and his company are in Mexico for the same reason other cannabis science and research companies are flocking there. The medical community in Mexico, it would appear, is ready to embrace cannabis. Just recently, on August 20, 2019, the first Mexican Association for Cannabis Research (Amexicann) was formed by scientists to develop protocols to classify the pharmaceutical, medicinal, industrial, and personal uses of medicinal marijuana.

Gustavo Oláiz, chairman of Amexicann, said that his association was founded to help public and private entities to conduct resources and efforts with the objective of investigating cannabis in its possible uses and derivatives, obtaining scientific evidence of its possible benefits, risks and consequences.

The organization first wants to identify the best marijuana genetics for medicinal use, and hemp genetics most effective for industrial use. Amexicann will also conduct medicinal cannabis research to establish their desired balance between the options of hemp, cannabidiol (CBD), or combinations with tetrahydrocanabidiol (THC) for therapeutic use. The organization’s third area of ​​research is in non-pharmaceutical medicinal use of cannabis.

Bridged by cannabis science, the best medical research minds from Mexico and the United States may be the first to develop solutions to the industry’s biggest challenges. Government acceptance of cannabis research, and access to myriad cannabis strains, make Mexican laboratories some of the likeliest to be where frictionless product testing and precise user profile dosing recommendations are both developed. With good protocols, processes, standards, science, and Good Manufacturing Practices (GMPs), cannabis researchers in Mexico can take on the industry’s hallmark challenges of product safety and predictability in outcome. 

Research and development of targeted therapeutic applications for cannabis can occur only through rigorous science. New compounds being explored in countries like Israel and Mexico are ripe for this type of robust research and development. “This type of work requires familiarity with and access to specific analytes and complexes,” Burk said, “we are excited to help bridge that gap.”

Main Image: Deposit Photos

Andre Bourque is a cannabis industry connector, executive advisor to several cannabis companies, brand strategy advisor, and a cannabis industry analyst. In addition to Benzinga, Andre’s articles have been featured in Forbes, The Huffington Post,, Yahoo Finance, CIO Magazine & ComputerWorld.
You can connect with him at @socialmktgfella on LinkedIn, Twitter, and Instagram.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

© 2019 Benzinga does not provide investment advice. All rights reserved.

High Country: Prep Your Skin For Winter With Pila Xian’s CBD Facial – Aspen Times

Courtesy Beboe Therapies

CBD is still reigning supreme as beauty’s queen ingredient and with winter arriving early this year, it’s the perfect time to experiment with adding the cannabis compound into your skincare routine.

Offseason is also the perfect time to catch up on your self-care appointments, which is why I was excited to learn that local massage therapist and esthetician Pila Xian has just added a CBD facial to her treatment menu. As owner of Heaven On Earth — a day spa dedicated to high-altitude living — Xian has led the local scene in cannabis-infused services. In 2016, she became the first in town to offer a CBD massage and now is also the first providing a custom CBD facial (Remède Spa at the St. Regis and O2 Aspen only offer CBD oil as an add-on to skin treatments).

Xian is most known, though, as a partner practitioner of the celebrity-beloved Intraceuticals Oxygen Facial, which is an all-natural alternative to more common clinical facials that use acid peels and irritating scrubs. After incorporating CBD into her own skincare routine, she’s combining it with her most requested treatment for an even more moisturizing and healing result.

“I’ve been using CBD on my face regularly for the past two years,” Xian explains. “Its natural properties are very soothing and calming to the skin and since it’s an anti-inflammatory, it minimizes issues related to skin sensitivity, especially irritations and redness. CBD is also a powerful antioxidant, which neutralizes free radicals that attach to and damage healthy skin cells. This damage leads to wrinkles, dark spots and even worse, disease.”

As her first client to try the Deep CBD Oxygen Facial last week, I left her studio with my skin looking smoother, lighter and brighter than it has all year. Xian is still vetting an official CBD brand collaborator, but for now is using GlyMed Plus and Color Up Therapeutics. Here’s Heaven On Earth’s step-by-step process for its debut Deep CBD Intraceuticals Oxygen Facial, plus my personally tested product picks to try at home to help put your freshest and healthiest face forward.

Step 1: Double cleanse with CBD-infused cleanser

“CBD excites the CB1 and CB2 Receptors of the endocannabinoid system (ECS) and enhances skin’s elasticity and resilience.”

High Country at-home: The Balancing Face Wash, Lab to Beauty, $40,

Step 2: Exfoliate

“I choose an exfoliant based on the client’s skin needs and ability. While the exfoliating enzymes do their magic (dissolving the top layer of dead skin cells), I perform an arm, shoulder and neck massage.”

High Country at-home: Bota Protective Skin Toner, $19.99,

Step 3: Extractions

“Depending on each client’s skin, I carefully and manually extract clogged pores and impurities. Please allow for an additional $28 fee and 15 extra minutes for this service.”

High Country at-home: Do not try this at home!

Step 4: Apply CBD mask and Intraceuticals Oxygen Facial treatment

“I first apply a CBD booster to the skin and then start the application of the oxygen wand. CBD is a powerful antioxidant, more powerful than Vitamins A, C and E (the most common used in skincare products), which help to protect our cells and their functions to keep them healthy and active, preventing premature aging in the skin. Following a CBD mask with my signature Intraceuticals Oxygen Facial, creates an even more moisturizing effect.”

High Country at-home: Beboe High Potency CBD Sheet Mask, $18,

Step 5: Apply CBD Serum

“I like to compare using facial serums to wearing a camisole. It’s a lightweight protector, but you wouldn’t go out in one without anything on top of it. Always apply serum underneath your daily moisturizer.”

High Country at-home: Saint Jane Luxury Beauty Serum, $125,

Step 6: Apply CBD Moisturizer

“Topical applications of CBD work to reduce inflammation on soft tissue. It works very quickly because of the multitude of CB2 receptors directly underneath the skin. When used this way, the CBD does not cross the blood/brain barrier and is non-psychoactive.”

High Country at-home: Grön Time-Reversing Face & Neck Cream, $50,

Step 7: Apply sunscreen

“Sunscreen is a twice a day, year-round necessity in the mountains! However, we haven’t yet seen CBD on the ingredient list for face formulas yet.”

High Country at-home: EltaMD UV Clear Broad-Spectrum SPF 46,

Katie Shapiro can be reached at and followed on Twitter @bykatieshapiro.

Edmonton man accused of running illegal cannabis grow-op – Global News

While marijuana has been legal in Canada for more than a year now, there are still rules surrounding how much you can grow on your own — and an Edmonton man has been accused of breaking those rules by running an illegal cannabis growing operation.

READ MORE: This is how you grow marijuana at home

On Friday, Oct. 25, police searched a northeast Edmonton home near 157 Avenue and 80 Street in the Mayliewan neighbourhood.

Inside, police said they found a grow-op that included about 130 viable cannabis plants, as well as dried cannabis, illegal cannabis edibles, psilocybin (magic) mushrooms and cannabis manufacturing equipment.

“Just like alcohol, cannabis is a regulated product,” EPS Cannabis Compliance Officer Cst. Dexx Williams said. “If you’re going to produce it at home, you need to comply with all municipal, provincial and federal requirements.”

Story continues below advertisement

The total seizure is estimated to be worth more than $148,000, police said.

READ MORE: Hundreds of cannabis stores in Alberta but users still turning to black market

Williams said those who don’t follow the rules face criminal and provincial charges, along with “substantial financial setbacks in order to bring your property into compliance.”

It is legal to grow up to four plants per household for personal use. However, in order to legally grow more for medical reasons or to grow cannabis that is intended for sale, growers must apply for a license through Health Canada and adhere to all municipal and provincial regulations, such as development permits and safety codes.

READ MORE: Almost a year after legalization, why do legal sellers offer home growers so little?

Ryan Paton, 35, is charged with possession of a controlled substance under the Controlled Drugs and Substances Act, as well as possession of cannabis for the purpose of unlawful distribution and cultivate or propagate more than four plants in a dwelling house, both charges under the federal Cannabis Act.

© 2019 Global News, a division of Corus Entertainment Inc.

Cannabis stocks fall as Curaleaf becomes latest company to scale back a big acquisition – MarketWatch

Cannabis stocks were mostly lower Thursday, led by Curaleaf Holdings, after the company became the latest to scale back a previously announced acquisition following a massive re-rating of risk in the sector in the past few months.

Wakefield Massachusetts-based Curaleaf CURLF, -8.25% CURA, -8.20%  said in May it had reached a deal to acquire the Select brand from Cura Partners Inc., in an all-stock deal valued at C$1.27 billion, or $948.8 million. On Wednesday, Curaleaf said the companies had mutually agreed to amend the base consideration payable to 55 million Curaleaf shares from an original 95.5 million.

The company said changes in market conditions prompted the move and said the remaining 40.6 million consideration would be payable to Select equity holders upon reaching certain revenue targets in calendar year 2020, starting at $130 million with a maximum of up to $240 million.

The company also said a federal antitrust review of the deal has been completed, clearing the path for the deal to close. Cannabis deals have taken longer to clear than deals in sectors that are not subject to a federal ban, as regulators said they needed time to educate themselves on the business.

Read also: Cannabis producer Hexo shutting down facilities amid deep staff cuts

“Select valuation has fallen dramatically over the last few months, but Curaleaf was able to lower immediate dilution and make total dilution more contingent on performance,” said MKM analyst Bill Kirk. With the HSR waiting period expired, “this is a small net positive for Curaleaf,” he added.

Curaleaf’s U.S.-listed shares fell about 6% Thursday, and have lost 38% of their value in the last three months.

See: One year on, Canada’s legal cannabis market is down but not out

Other deals have also been scrapped or amended in the wake of the steep selloff in the sector. In early October, retailer MedMen Enterprises MMNFF, -0.96%  said it was abandoning its plan to buy PharmaCann LLC in a stock deal that was valued at $682 million when it was announced. MedMen shares fell 2.9% and are down 50% in the last three months.

See now: The U.S. cannabis industry needs access to the U.S. stock markets

Last week, Cresco Labs CL, -6.44%  announced the completion of an antitrust review of its acquisition of Origin House and said the parties were now working on “mutually agreeable” terms. The deal announced in April was originally valued at C$1.1 billion. Cresco Labs shares have fallen 47% since that time, and were down 5% Thursday.

Cronos shares CRON, -1.08% CRON, -1.46%  were down 2.1%. The chief financial officer of Altria Group, which has a $1.8 billion investment in Cronos, said the tobacco company is happy with its cannabis partner.

Read: Marijuana stocks, after declines of over 50%, are now only ludicrously overpriced

On the company’s earnings call with analysts, Gifford said Cronos is making progress and executing on its growth strategy. Cronos closed on the acquisition of Redwood Holding Group LLC in the third quarter, giving it a line of CBD-based skin care and other consumer products that are sold online and through retail partners in the U.S. under the Lord Jones brand. “

We believe the acquisition fits well into Cronos’ strategy of building differentiated brands and disruptive and intellectual property,” said the executive, according to a FactSet transcript.

Elsewhere in the sector, market leader Canopy Growth Corp. CGC, -0.99% WEED, -0.72%  was down 1.3%, Tilray Inc. TLRY, +0.45%  was down 0.2%, Aphria Inc. APHA, -0.99% APHA, -0.75%  was down 0.1% and Aurora Cannabis ACB, -0.55% ACB, -0.63%  was down 0.6%.

Aleafia Health ALEAF, +2.59% ALEF, +1.41%  was down 1.1%, Hexo was down 4% and Green Organic Dutchman was down 1.1%.

The ETFMG Alternative Harvest ETF MJ, -0.21%  was down 0.5%, while the Horizons Marijuana Life Sciences ETF HMMJ, -0.66%  was down 0.4%.

The S&P 500 SPX, -0.30%  was down 0.6% and the Dow Jones Industrial Average DJIA, -0.52%  was off 0.8%.

Cannabis Watch: Click here for all of MarketWatch’s coverage of cannabis companies

How Direct CBD Online encourages CBD discovery and savings – Leafly


This article is brought to you by Direct CBD Online, curating CBD’s most exclusive brands in one easy-to-find place.

Attracting the nation’s most exclusive CBD brands isn’t an easy feat, but it’s one that Direct CBD Online has made the cornerstone of their business. With more than 80 different CBD brands for customers to choose from, Direct CBD Online is committed to keeping its clientele stay aware of all the latest CBD trends and products. And it doesn’t stop there.

CBD products for the whole household

(Courtesy of Direct CBD Online)

A thriving CBD hub is nothing without the love of their customers. When they started, the team at Direct CBD Online knew they’d have to pay close attention to where the demand for CBD was coming from.

“One thing we’ve learned about our customers is that they need CBD for diverse reasons. For example, when we first started, we thought that people 40 and over were going to be our main consumers because they are more mature and focused on holistic wellness, but we quickly saw that people of many ages want CBD,” says John Wiesehan III, CEO of Direct CBD Online. “Lots of our customers in their 20s and 30s are interested in CBD for potential mood benefits. We’ve seen a spike in athletes that want to try to address joint pain and daily wellness, too.”

With so many brands to choose from, customers can shop for themselves or their loved ones. This is because the Direct CBD Online marketplace represents a unique opportunity where multiple brands in multiple formats can all coexist in one place.

The scale of their product inventory saves customers’ time and connects them to CBD for their whole household, including partners, pets, elderly parents, and more.

An exclusive CBD brand experience online

(Courtesy of Direct CBD Online)

While the main focus of their business is providing a wide selection of CBD products, the team at Direct CBD Online knows the exclusive brands they carry also require premier customer service. This high level of service is exemplified by the site’s safety measures and order fulfillment process.

“Maintaining a platform of safe brands is important to us. It means that we have to pay attention to the news and the market as a whole, but it’s worth it. If there’s a brand with poor safety practices or one that’s receiving negative press, especially from the medical community, we remove them from our marketplace immediately. It’s our responsibility, but we’re happy to do it to make sure everyone stays happy and healthy,” John says.

Regardless of what brand or brands a customer chooses, Direct CBD Online makes sure to provide exclusive customer service treatment. One way the site does this is by eliminating the delivery middleman and tracking CBD orders from the moment a customer clicks “buy” online to the moment they say “hi” to their delivery in-person.

Customers who shop on Direct CBD Online receive their orders in 4-7 days with options for free and expedited shipping – a speediness that makes all the difference for anyone who has immediate CBD needs.

“Stocking everything in our own warehouse allows us to move quickly and get CBD products to our customers in 4-7 days. When someone counts on CBD for their daily routine or is really eager to try CBD, it is important to get our products into customers’ hands and control the level of customer experience they get with it,” says John.

Rewarding CBD exploration and discovery

(Courtesy of Direct CBD Online)

A daily CBD routine is an investment, so Direct CBD Online does its best to make sure customers feel rewarded even after they receive their products. The site’s rewards program is extensive, providing points that translate into real dollars. Customers can earn points by liking and following Direct CBD Online social media, leaving reviews, and creating an account on their website.

It’s the quintessential way to meet CBD consumers where they are.

“With everything we do, we want to make the CBD experience better and more engaging for our customers,” John says. “Engaging with them is like the icing on the cake to their customer experience, then we can improve our business on their behalf, and continue to earn their loyalty with every purchase.”


Los Angelenos face new delays for legal cannabis – Leafly

October 31, 2019



The city of Los Angeles, which has 4 million people and a huge illicit cannabis market associated with more than 100 vaping injuries and one death, has just 189 licensed cannabis stores. The hundreds of unlicensed, illicit stores that feed tainted vaping products into the market are thriving in part because there are so few licensed and regulated stores.

Now the LA city council president has asked for a re-do of new store licensing, which could further slow the city’s transition to legality.

Due to red tape, experts expect as few as 15 new stores to open by Jan. 1, 2020. No more than 300 licensed stores will be open by Jan. 1, 2021, they estimate.

By contrast, Denver has a population of 620,000 people and 518 stores.


Tainted vape pens selling 2-for-1 in illegal California stores

The Oct. 28 letter from City Council President Herb Wesson to Department of Cannabis Regulation head Cat Packer calls for an audit and re-do of so-called “Phase 3 Retail Round 1 Social Equity Program” licensing.

Wesson called the license process unfair, and claimed some applicants got early access to the online application form. The DCR dismissed those concerns in a report to the City Council last Friday.

It’s not clear if Wesson’s requested re-do will happen. The City Council would need to vote and approve it. (Leafly is awaiting returned calls from Wesson’s office for comment.)

Forecast: More drama, more sick, no stores

The drama is more of the same dysfunction that dates to the origin of medical cannabis in 1996, under California’s medical marijuana initiative, Proposition 215.

From the Venice Beach “medical cannabis nurse” era, to the shootings at unregulated collectives, to today’s VAPI outbreak, Los Angeles has consistently been America’s cannabis problem child. It’s the place officials in other cities and states try to avoid copying.

Unlike other major California cities, LA officials have yet to issue a fully complete annual license to any cannabis store in the city. Instead, LA’s licensed stores operate with temporary licenses, pending completion of more paperwork.

Storefront cannabis dispensaries exploded in popularity in 2004 after the California legislature created a collective legal defense for organizations known as medical marijuana collectives. Many cities responded with crackdowns. When those didn’t work, they turned to regulations and licensing.

L.A. catching up on regulatory homework

Los Angeles also tried crackdowns in the form of police raids. Those failed, so in 2013 city officials half-regulated stores with local Proposition D, which granted “limited immunity” to about 135 medical marijuana collectives operating out of storefronts. But limited immunity wasn’t official licensure, which was the path taken by Oakland, Berkeley, San Francisco, San Jose, Sacramento, and other cities.

Since then, LA has consistently failed to do its homework and enact regulations that actually work. The biggest example came on Jan. 1, 2018, when licensed adult-use cannabis sales started statewide across California, but not in Los Angeles. While other cities had their regulatory agencies staffed and ready, DCR president Cat Packer had a grand total of three employees.

On Jan. 1, 2019, the state’s “medical cannabis collective” legal defense officially expired. Old-school collectives can’t sell cannabis anymore. And yet LA still has hundreds—perhaps thousands—of them. In an effort to shut them down, a city-led task force shut off power to 194 unlicensed dispensaries in August.

This fall, Los Angeles’ latest multi-phase, multi-round licensing process proved ripe for conflict. More than 800 groups applied for 100 applications in a little over three minutes when the application process officially opened at 10 a.m. on Sept. 3. The flood of applicants came because the city’s process was set up to review applications on a first-come, first-served basis. The losers are widely expected to sue the winners, the city, or both, claiming some disadvantage. This isn’t uncommon in other cities and states, but LA licenses have long been political footballs. Delays are all but guaranteed.


LA dispensary crime reports doubled since 2010, fueled by unlicensed stores

DCR head Packer addressed the City Council on Oct. 25. In her remarks, she included no target dates for licensed, operational stores in the next two years. In the past year the DCR has staffed up from three to 26 people, but Packer lacks the authority to fast-track new licensees by issuing temporary licenses. Nor can she and her agency raise the store cap from about 500 to what it needs to be—at least 2,000. Only the LA City Council can do that.

Meanwhile, tainted THC vape carts sell two-for-one in illegal LA stores. Delivery services and pop-up markets operate with near-impunity and sicken consumers with toxic products. Owners of the best licensed stores barely break even, they say, while street and online dealers run laps around them all.

Taken in context, Wesson’s suspension request continues the same broken public health and safety policy Los Angelenos have strangely tolerated for a generation now.

(Main image: After some called the process unfair, Los Angeles City Council president Herb Wesson has called for suspending and re-doing cannabis store licensing. (AP File Photo/Ringo H.W. Chiu)


David Downs's Bio Image

David Downs

David Downs directs news and lifestyle coverage as the California Bureau Chief for He’s written for WIRED, Rolling Stone and Billboard, and is the former cannabis editor of the San Francisco Chronicle, as well as the author of several cannabis books including ‚Marijuana Harvest’ by Ed Rosenthal and David Downs. He co-hosts The Hash podcast. TW: @davidrdowns | IG @daviddowns

South Central Kentucky Drug Task Force warns of increasing THC vape products – WBKO

RUSSELLVILLE, Ky. (WBKO) – The South Central Kentucky Drug Task Force warns of increasing THC vape products found through traffic stops, search warrants, and general calls for service.

The vape cartridges in the attached pictures are actual cartridges seized by the task force. They say the same “Dank” branded vape cartridges are unregulated and sold on the black market.

The amount of THC allegedly present in these cartridges is printed on the side of the box and is more than six times the THC found in the strongest marijuana strains that they regularly seize.

The drug task force says “Dank” cartridges are typically sold for a lot less than a legal vape cartridge in legal states, but the “Dank” brand isn’t really a brand. Dealers can buy the empty “Dank” branded boxes and empty vape cartridges for pennies online. They then fill the cartridges with their own purchased or manufactured cannabis oil and sell them on the streets.

They say due to the cartridges being unregulated, there is no way to know what other types of chemicals are present and it’s believed that these types of vape cartridges, specifically the ones using this brand name, may be responsible for the vape illnesses.

CBD oil in Mount Pleasant and across the nation – Central Michigan Life

Nichole Sanborn has spent the last four years at the Family Video store on Mission Street providing Mount Pleasant and Central Michigan University students with the latest blockbuster movies and video games.

Before her store started stocking cannabidiol (CBD) products, Sanborn wanted to make sure her customers were getting what they paid for. 

She decided to order a strong dosage to aid her chronic neck and back pain. If what she ordered showed no effect, there was no way she could support it. The treatment, Sanborn said, was a success.

“As far as pain management goes, this was a huge change in my life,” she said. 

Family Video began selling CBD in May. It began with around 70 stores in Michigan and 250 stores nationwide. Sanborn said the products were an immediate success in the Mount Pleasant branch, selling over $1,000 in the first week.  

“We started to get people in the store that we’ve never seen before,” Sanborn said. “Lots of people seem excited and wanted to learn about it.”

While most assume video stores have become obsolete, Family Video has been able to adapt to the digital age by adopting the newly legalized CBD market.

What is CBD?

Marijuana, hemp, CBD and THC are words that get thrown into the cannabinoid discussion, although the distinction between terms is blurry.

At the basics, CBD is one of many chemical compounds found in different species of cannabis plants.

While CBD can be found in marijuana, it’s mainly extracted from a cousin species: the hemp plant. Unlike THC, which produces the psychoactive “high,” CBD’s effects have been proven non-intoxicating.

CBD has recently been praised for its multiple medicinal properties. According to the National Institute on Drug Abuse, “(CBD) may be useful in reducing pain and inflammation, controlling epileptic seizures, and possibly even treating mental illness and addictions.” 

Dr. Tamara Moutsatson of the McLaren Central Michigan hospital has been suggesting CBD products to her patients with back pain or joint pain and tracking its success.

„Eventually (CBD) may end up rivaling Tylenol or Motrin for pain relief,” Moutsatson said. „I’m surprised how many people are trying it without me even suggesting it.”


Previous generations saw all forms of cannabis illegal under the Marihuana Tax Act of 1937 and strictly criminalized in the 70s.  

For decades, federal law did not differentiate the hemp plant and CBD from marijuana and THC.  

In 2018 hemp growers and CBD manufacturers rejoiced when the federal government struck hemp and its cannabinoids from the list of controlled substances. 

Prior to this, the 2014 Farm Bill gave America its first taste of hemp farming. It allowed institutions of higher education and state agriculture departments to grow hemp with permission from the state. 

Since then, studies like those from the World Health Organization concluded, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential…. To date, there is no evidence of public health-related problems associated with the use of pure CBD.” 

According to Sanborn, CBD sales continued to average around $800 a week and are expected to climb. She predicts that nearly 85% of Family Video’s clientele are CMU students.  

Regulations and warnings

Despite legalization by the 2018 Farm Bill, CBD still falls into a legal grey area. 

„Law enforcement is learning about CBD regulations as fast as lawmakers come up with them,” Officer Autume Balcom of the Mount Pleasant Police department said. „There are still a lot of unanswered questions.”

The Michigan Department of Licensing and Regulatory Affairs still classify any substance with a THC concentration above 0.3 percent as marijuana. In order for a CBD product to be sold, it must pure and distributed from a licensed grower and processor. 

According to Balcom, Family Video and other retailers are able to distribute CBD products with ease because of the low THC levels. Any higher than the legal limit and it would be classified as marijuana. 

Therefore, the products sold at Family Video comply with the Department of Licensing and Regulatory Affairs. However, like all marketed CBD products, they are yet to be approved by the Food and Drug Administration.

In June 2018 the FDA approved a CBD treatment for two rare forms of epilepsy called Epidiolex. Aside from this one prescription drug, the FDA has not approved any other products containing CBD.

Without FDA approval, some products are being marketed with unproven medical claims. This may lead consumers to put off important medical care and receive a proper diagnosis. Researchers urge people to consult with a healthcare provider before putting a CBD product to use.

To learn more about their research process and unanswered questions, visit the FDA’s website.

While Family Video was one of the first to sell CBD in the area, the competition has skyrocketed in just a 1-mile radius. Many local gas stations, pharmacies, and smoke shops have begun supplying the new health craze. 

The small store has sat on Mission St. since 2000, making the property older than incoming CMU freshmen.  

“You hear a lot of companies say they love their customers,” she said. “This is the first place I’ve worked where I can feel it on a daily basis.” 

Family Video receives blockbuster movies nearly 30 days before most streaming services. Their catalog is expansive with a wide selection of movies, video games and now CBD products ranging from $3 to $150. 

To an outsider, a video store selling CBD products may seem unusual, but the new market is expected to keep the company alive for many years to come. 

Good Day Chocolate to launch line of CBD chocolate – Candy Industry

Candy Industry logoCandy Industry logo